"Obesity" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A status with BODY WEIGHT that is grossly above the acceptable or desirable weight, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
Descriptor ID |
D009765
|
MeSH Number(s) |
C18.654.726.500 C23.888.144.699.500 E01.370.600.115.100.160.120.699.500 G07.100.100.160.120.699.500
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Obesity".
Below are MeSH descriptors whose meaning is more specific than "Obesity".
This graph shows the total number of publications written about "Obesity" by people in this website by year, and whether "Obesity" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 5 | 2 | 7 |
1995 | 7 | 3 | 10 |
1996 | 5 | 1 | 6 |
1997 | 4 | 8 | 12 |
1998 | 12 | 4 | 16 |
1999 | 10 | 1 | 11 |
2000 | 17 | 2 | 19 |
2001 | 9 | 3 | 12 |
2002 | 15 | 5 | 20 |
2003 | 24 | 10 | 34 |
2004 | 31 | 24 | 55 |
2005 | 37 | 15 | 52 |
2006 | 36 | 17 | 53 |
2007 | 31 | 18 | 49 |
2008 | 56 | 25 | 81 |
2009 | 50 | 18 | 68 |
2010 | 50 | 28 | 78 |
2011 | 72 | 30 | 102 |
2012 | 72 | 29 | 101 |
2013 | 93 | 47 | 140 |
2014 | 62 | 36 | 98 |
2015 | 73 | 30 | 103 |
2016 | 57 | 37 | 94 |
2017 | 75 | 27 | 102 |
2018 | 49 | 20 | 69 |
2019 | 45 | 22 | 67 |
2020 | 48 | 35 | 83 |
2021 | 35 | 49 | 84 |
2022 | 9 | 64 | 73 |
2023 | 7 | 58 | 65 |
2024 | 0 | 12 | 12 |
To return to the timeline,
click here.
Below are the most recent publications written about "Obesity" by people in Profiles.
-
Distinct Amino Acid Profile Characterizes Youth With or at Risk for Type 2 Diabetes. Diabetes. 2024 Apr 01; 73(4):628-636.
-
Embracing cancer complexity: Hallmarks of systemic disease. Cell. 2024 Mar 28; 187(7):1589-1616.
-
Approaches to estimate bidirectional causal effects using Mendelian randomization with application to body mass index and fasting glucose. PLoS One. 2024; 19(3):e0293510.
-
In adults with overweight or obesity and CVD, but without diabetes, semaglutide reduced MACE at a mean 40 mo. Ann Intern Med. 2024 Mar; 177(3):JC31.
-
Adipose Tissue Dysfunction and Energy Balance Paradigms in People Living With HIV. Endocr Rev. 2024 Mar 04; 45(2):190-209.
-
Association of Lifestyle Intervention With Risk for Cardiovascular Events Differs by Level of Glycated Hemoglobin. J Clin Endocrinol Metab. 2024 Feb 20; 109(3):e1012-e1019.
-
Metabolic syndrome: imaging features and clinical outcomes. Br J Radiol. 2024 Feb 02; 97(1154):292-305.
-
Circulating microRNA expression and nonalcoholic fatty liver disease in adolescents with severe obesity. World J Gastroenterol. 2024 Jan 28; 30(4):332-345.
-
Observational cohort investigating health outcomes and healthcare costs after metabolic and bariatric surgery: a study protocol. BMJ Open. 2024 Jan 25; 14(1):e077143.
-
Response to Jacob and Varughese. Obes Surg. 2024 Apr; 34(4):1379.